allopurinol (Compound)

Synonyms:allopurinol, 315-30-0, 1H-Pyrazolo[3,4-d]pyrimidin-4-ol, Zyloprim, Lopurin, Zyloric, Suspendol, Atisuril, Bleminol, Caplenal, Takanarumin, Uripurinol, Embarin, Foligan, Milurit, Progout, Urosin, Anoprolin, Cellidrin, Epidropal, Ailural, Allopur, Allural, Alositol, Bloxanth, Cosuric, Hamarin, Ledopur, Lysuron, Uricemil, Uriprim, Xanturat, Aloral, Anzief, Apurin, Apurol, Geapur, Gotax, Remid, Urbol, Urolit, Urtias, 4-Hydroxypyrazolo[3,4-d]pyrimidine, Ketobun-A, Apulonga, Dabrosin, Dabroson, Ketanrift, Miniplanor, Nektrohan, Adenock, Allozym, Aluline, Gichtex, Monarch, Riball, 1H-Pyrazolo[3,4-d]pyrimidin-4(5H)-one, Hexanuret, Epuric, Allo-Puren, 4-HPP, Allopurinol(I), Dura Al, Allopurinolum, 1H-Pyrazolo(3,4-d)pyrimidin-4-ol, Urtias 100, 4-Hydroxypyrazolopyrimidine, 4-Hydroxy-1H-pyrazolo(3,4-d)pyrimidine, Alopurinol, Aloprim, 180749-06-8, 180749-08-0, 1H-pyrazolo[3,4-d]pyrimidin-4(7H)-one, 4-Hydroxy-3,4-pyrazolopyrimidine, 73334-58-4, NSC-1390, 4-Hydroxypyrazolo(3,4-d)pyrimidine, Alopurinol [INN-Spanish], Allopurinolum [INN-Latin], 2H-Pyrazolo[3,4-d]pyrimidin-4-ol, 1H-pyrazolo[3,4-d]pyrimidin-4(2H)-one, 4-Hydroxypyrazolyl(3,4-d)pyrimidine, 4H-Pyrazolo(3,4-d)pyrimidin-4-one, BW 56-158, 4'-Hydroxypyrazolol(3,4-d)pyrimidine, AL-100, Zyloprim (TN), 180749-09-1, 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one, BW-56-158, B. W. 56-158, 1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidine-4-one, 4H-Pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro-, 4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-, 1,5-Dihydropyrazolo[3,4-d]pyrimidin-4-one, MFCD00599413, MLS000069453, 180749-07-9, 184789-03-5, 916980-04-6, CHEBI:40279, NSC-101655, 63CZ7GJN5I, SMR000059083, 4-Hydroxy-1H-pyrazolo[3,4-d]pyrimidine, 1H-Pyrazolo[3,4-d]pyrimidin-4-ol (9CI), 4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,7-dihydro- (9CI), 1H,2H,4H-pyrazolo[3,4-d]pyrimidin-4-one, 1H,4H,7H-pyrazolo[3,4-d]pyrimidin-4-one, DTXSID4022573, NSC1390, 4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,2-dihydro-, NSC101655, 9002-17-9, NCGC00015094-02, NCGC00094580-04, 4H-Pyrazolo[3,4-d]pyrimidin-4-one, 2,5-dihydro- (9CI), 4H-Pyrazolo[3,4-d]pyrimidin-4-one, 2,7-dihydro- (9CI), BW 56158, BW-56158, Sigapurol, Uritas, 1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one, 1,5-Dihydro-pyrazolo[3,4-d]pyrimidin-4-one, DTXCID502573, 4H-Pyrazolo[3, 1,5-dihydro-, Ailurial, WLN: T56 BMN GN INJ FQ, Xanthine oxidase, 4-Hydroxypyrazolyl[3,4-d]pyrimidine, 4'-Hydroxypyrazolol[3,4-d]pyrimidine, NSC 1390, CAS-315-30-0, CCRIS 626, NSC 101655, HSDB 3004, SR-05000001983, EINECS 206-250-9, UNII-63CZ7GJN5I, Hexanurat, Uricto, ATH008, 4-Hydroxypyrazol[3,4-D]pyrimidine, Prestwick_511, Xanthomax-100, Xanthomax-300, 4H-Pyrazolo[3,4-d]pyrimidin-4-one,1,2-dihydro-, Aluline 100, Aluline 300, Hamarin 100, Hamarin 300, Zyloric-300, Allopurinol [USAN:USP:INN:BAN:JAN], Allopurinol (Zyloprim), Spectrum_000026, ALLOPURINOL [MI], Opera_ID_1680, Spectrum2_000098, Spectrum3_000289, Spectrum4_000135, Spectrum5_000768, ALLOPURINOL [INN], ALLOPURINOL [JAN], Lopac-A-8003, 1,4-d]pyrimidin-4-one, ALLOPURINOL [HSDB], ALLOPURINOL [USAN], A 8003, cid_2094, SCHEMBL4627, ALLOPURINOL [MART.], CHEMBL1467, NCIOpen2_001825, Lopac0_000102, ALLOPURINOL [USP-RS], ALLOPURINOL [WHO-DD], ALLOPURINOL [WHO-IP], BSPBio_001798, KBioGR_000550, KBioSS_000386, MLS001148183, US9138393, Allopurinol, US9144538, Allopurinol, DivK1c_000685, SPECTRUM1500108, SPBio_000056, ALLOPURINOLUM [WHO-IP], GTPL6795, SCHEMBL1128219, Allopurinol (JP17/USP/INN), BDBM35440, HMS502C07, KBio1_000685, KBio2_000386, KBio2_002954, KBio2_005522, KBio3_001298, ALLOPURINOL [EP IMPURITY], ALLOPURINOL [ORANGE BOOK], NINDS_000685, ALLOPURINOL [EP MONOGRAPH], BDBM181133, HMS1920A15, HMS2091G15, HMS2234M09, HMS3259K13, HMS3260E06, HMS3371I11, HMS3651O13, HMS3714L22, Pharmakon1600-01500108, ALLOPURINOL [USP MONOGRAPH], ACT02732, AMY18272, BCP26973, DUZALLO COMPONENT ALLOPURINOL, HY-B0219, STR05189, Tox21_110082, Tox21_200922, Tox21_500102, 4-Hydroxy-pyrazolo[3,4-d]pyrimidin, AC-019, BBL009959, BDBM50016784, BDBM50140241, CCG-38916, NSC755858, s1630, SC1118, SC2251, STK378584, STK711106, AKOS000267490, AKOS000269759, AKOS024255717, Tox21_110082_1, Allopurinol, xanthine oxidase inhibitor, CCG-204197, CCG-221406, CCG-266128, DB00437, LP00102, NC00492, NSC-755858, SB10164, SDCCGSBI-0050090.P005, IDI1_000685, NCGC00015094-01, NCGC00015094-03, NCGC00015094-04, NCGC00015094-05, NCGC00015094-06, NCGC00015094-07, NCGC00015094-08, NCGC00015094-22, NCGC00091134-01, NCGC00091134-02, NCGC00091134-03, NCGC00094580-01, NCGC00094580-02, NCGC00094580-05, NCGC00188948-01, NCGC00258476-01, NCGC00260787-01, TS-00028, SBI-0050090.P004, DB-065332, 2H-Pyrazolo[3,4-d]pyrimidin-4-ol (9CI), A0907, EU-0100102, FT-0602537, FT-0661492, FT-0685730, FT-0764079, SW199406-4, 1,5-dihydropyrazolo[3,4-d]-pyrimidin-4-one, EN300-34144, VU0611037-1, BIM-0061756.0001, D00224, F18007, AB00173448-03, AB00173448-04, AB00173448_05, AB01274719-01, AB01274719_02, 4h-pyrazolo[3,4-d]pyrimidin-4-one,1,7-dihydro-, 4h-pyrazolo[3,4-d]pyrimidin-4-one,2,5-dihydro-, 4h-pyrazolo[3,4-d]pyrimidin-4-one,2,7-dihydro-, AB-323/25048497, Allopurinol (4-Hydroxypyrazolo[3,4-d]pyrimidine), Q412486, SR-01000075595, 4H-pyrazolo[3,4-d]pyrimidin-4-one, 1,7-dihydro-, J-504736, SR-01000075595-1, SR-05000001983-1, SR-05000001983-2, W-106892, F2173-0394, F3329-0375, Z104486670, Allopurinol, British Pharmacopoeia (BP) Reference Standard, Allopurinol, European Pharmacopoeia (EP) Reference Standard, Allopurinol, United States Pharmacopeia (USP) Reference Standard, 1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one Synonym: Allopurinol, Allopurinol, Pharmaceutical Secondary Standard; Certified Reference Material, 1H-Pyrazolo[3,4-d]pyrimidin-4-ol;1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE, 184856-42-6
Pubchem:PUBCHEM:2094
Id:3c6e4307-2e7e-55af-8b67-15db1be23a47
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View allopurinol's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for allopurinol.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with allopurinol.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.